Is this you?
Request access for Headlands Research with your @headlandsresearch.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Headlands Research
Unclaimed profileSite Network · Lake Worth, FL · ~15+ sites
Intera lens
ICP 7Lift (cardio sample) 0.18Recruit soph 0.57
Quality Scorecard (1–100)
Overall67Recruit80Ops64Sponsor60Ther60
Performance (observed)
Historical trials
188
Completed
81
Terminated/Withdrawn
18
Completion rate
82%
Active now
87
Phase 2
62
Phase 3
101
Realized enrollment
445,725
First study year
2017
Years active
9
Match confidence
high
Enrollment velocity (inf)
49,525
Therapeutic
Areas
CNS, mental health, vaccines, metabolic, cardiovascular, dermatology, GI, oncology, orthopedics, pediatrics, multiple others
Specialties
CNS, mental health, vaccines, metabolism/endocrinology, oncology, cardiology, dermatology, immunology, infectious disease
Breadth (conditions)
129
Languages
English
States
Multiple (FL, CA, CO, NE, TX, and Canada)
Recruitment (web observed)
Trial Finder
Yes
Patient database
Y; 130,000+ participants
Recruitment pages
Yes
Advertises recruitment
Yes
SEO
Strong; Comprehensive capabilities and site pages
Capability notes
Large-volume recruitment and retention of diverse populations; established site database and physician partnerships
Relationships
Sponsors
Eli Lilly and Company; Pfizer; Novo Nordisk A/S; ModernaTX, Inc.; AbbVie; Merck Sharp & Dohme LLC
CROs
Worldwide Clinical Trials
Partnerships
None listed
Owner / parent
THL Partners (acquiring from KKR, August 2025)
Funding
THL Partners majority acquisition from KKR (Aug 2025)
Acquisitions
Clinical Trials Research (Sacramento/Lincoln, CA, June 2026); acquired by THL
Expansion
Y; 20+ sites; THL acquisition from KKR (Aug 2025); clinical trials research acquisition (June 2026)
Recent hiring
Y; Clinical site managers and research coordinators
Capacity & people
Investigators
—
Coordinators
—
CEO
Kyle Burtnett
VP Clinical Ops
Unknown
VP Site Ops
Unknown
VP Recruitment
Lauren Chazal (Chief Business Development Officer)
Emails
kyle.burtnett@headlandsresearch.com; lauren.chazal@headlandsresearch.com
Tech & DCT
CTMS
Unknown (proprietary)
EHR
Proprietary EHR partnerships; referral access
eSource
Yes
eConsent
Yes
Builds tech
Unknown
DCT / decentralized
Y; eSource, eRegulatory, real-time data access
Tech stack
Not explicitly mentioned
Recruiting visible
Y
Notes
Multinational integrated site network, 550+ clinical staff, 5,000+ trials completed. Acquired by THL Partners (growth signal). Multiple states/Canada. Strong on diverse population recruitment. Limited visible tech innovation. Fit: Good multi-site volume, acquisition/growth trajectory, diverse therapeutic areas, but lacks visible tech/recruitment marketing. [Validated: 10 active recruiting cardiometabolic trials on ClinicalTrials.gov.]
Recommendation features (sample indication)
Ind fit 0.42Liftability 0.18Overall67
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.